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http:WHAT THIS PAPER ADDS
There is controversy about the beneﬁt of routine ultrasound (US) use over traditional clinical examination and
selective US use. This meta-analysis of ﬁve randomized controlled trials reveals that routine ultrasound mapping
before the creation of arteriovenous ﬁstulae signiﬁcantly reduces the immediate failure rate compared with
clinical examination and selective US use.Objective/background: Existing guidelines suggest routine use of pre-operative color Doppler ultrasound (DUS)
vessel mapping before the creation of arteriovenous ﬁstulae (AVF); however, there is controversy about its
beneﬁt over traditional clinical examination or selective ultrasound use.
Methods: This was a systematic review and meta-analysis of randomized controlled trials (RCTs) comparing
routine DUS mapping before the creation of AVF with patients for whom the decision for AVF placement was
based on clinical examination and selective ultrasound use. A search of MEDLINE/PubMed, SCOPUS, and the
Cochrane Library was carried out in June 2014. The analyzed outcome measures were the immediate failure rate
and the early/midterm adequacy of the ﬁstula for hemodialysis. Additionally, assessment of the methodological
quality of the included studies was carried out.
Results: Five studies (574 patients) were analyzed. A random effects model was used to pool the data. The
pooled odds ratio (OR) for the immediate failure rate was 0.32 (95% conﬁdence interval [CI] 0.17e0.60; p < .01),
which was signiﬁcantly in favor of the DUS mapping group. The pooled OR for the early/midterm adequacy for
hemodialysis was 0.66 (95% CI 0.42e1.03; p ¼ .06), with a trend in favor of the DUS mapping group; however,
subgroup analysis revealed that routine DUS mapping was more beneﬁcial than selective DUS (p < .05).
Conclusion: The available evidence, based mainly on moderate quality RCTs, suggests that the pre-operative
clinical examination should always be supplemented with routine DUS mapping before AVF creation. This policy
avoids negative surgical explorations and signiﬁcantly reduces the immediate AVF failure rate.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Achieving functioning arteriovenous ﬁstulae (AVF) in pa-
tients with end stage renal disease remains challenging, as
the primary failure rate reaches 40%.1 Pre-operative color
Doppler ultrasound (DUS) examination may result in
improved AVF placement and adequacy for hemodialysis;
however, there is no consensus on the role of routine DUS
mapping prior to AVF creation.responding author.
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//dx.doi.org/10.1016/j.ejvs.2015.01.012Previous non-randomized comparative studies were in
favor of routine pre-operative ultrasound mapping,2e5
while a meta-analysis including three randomized clinical
trials (RCTs) with contradicting results and investigating only
the immediate failure rate failed to reach statistical signif-
icance.6 Despite the lack of indisputable evidence to sup-
port routine pre-operative ultrasound examination, the
existing Disease Outcomes Quality Initiative guidelines and
European Best Practice Guidelines suggest its routine use
based on level II evidence.7,8
A systematic review and meta-analysis was carried out
including recent data, with the primary aim of comparing
routine DUS mapping before AVF creation with AVF creation
Figure 1. Flow chart showing the selection process. Note.
RCT ¼ randomized controlled trial.
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(US) use.
METHODS
Methodological assessment
This meta-analysis was carried out in accordance with the
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses guidelines.9 Study selection and abstraction
of data was done in duplicate; two of the authors (M.K.L.
and D.G.C.) performed an independent assessment. For
each trial included in the meta-analysis, the number of
patients who reached an end point and the total number of
patients in the groups were extracted by the two authors
and entered into the meta-analysis software; any
disagreement was resolved by discussion. The same policy
was followed with regard to the quality and the risk of bias
assessment of the included studies.
The methodological quality of each one of the studies
was evaluated using the Jadad scale.10 Three main items
were scored (randomization, double blindness, and with-
drawals and dropouts), and a maximum score of ﬁve could
be obtained. The risk of bias of the included studies was
assessed by considering ﬁve domains (randomization pro-
cedure, allocation concealment, blinding of participants,
blinding of outcome assessment, and follow up data).
Search strategy
A systematic literature search for studies in all languages
was carried out in June 2014 via MEDLINE/PubMed, SCO-
PUS, and the Cochrane Library using the following keywords
with Boolean operators: (mapping OR ultrasound) AND
(“vascular access” OR “arteriovenous ﬁstula”) AND (pre-
operative OR peri-operative). References in retrieved arti-
cles were manually searched for additional material.
Inclusion criteria
Studies were eligible for inclusion provided they fulﬁlled the
following criteria: (1) they should be RCTs; (2) they should
report on a cohort of patients evaluated pre-operatively
only with clinical examination or selective DUS use and a
cohort evaluated pre-operatively with routine DUS mapping
before the creation of an AVF; and (3) they should report
the post-operative outcome. Non-RCTs, duplicates, and
irrelevant citations were excluded. No relevant RCTs that did
not fulﬁll the inclusion criteria were identiﬁed. Outcomes of
interest were (1) the immediate failure rate, deﬁned as
access thrombosis or absence of thrill within the ﬁrst 24e48
hours of surgery, or inadequate vein found at dissection
with no subsequent AVF creation; (2) early/midterm ade-
quacy, deﬁned as usability for hemodialysis, at 1 or 6
months post-operatively; and (3) the primary patency or
primary assisted patency at a time interval of 1 year.
Analysis
Data were extracted from the studies and entered into a
computer program. Immediate and early/midterm failureswere recorded as adverse events. The pooled results (odds
ratio [OR] and 95% conﬁdence intervals [CI]) for all com-
bined studies were calculated and displayed using a random
effects model, despite the low heterogeneity owing to the
fact that US instrumentation, the DUS criteria used, and the
surgical technique varied substantially among the studies.
Sensitivity (subgroup) analysis was performed, including
studies comparing pre-operative evaluation with routine
DUS versus selective DUS, and excluding studies comparing
routine DUS with clinical examination only.
The probability of an adverse event occurring in one
group or the other was presented as the OR, where an OR
> 1 indicated a lower failure rate in the group that was
evaluated only with clinical examination plus selective US
use; and an OR < 1 indicated a lower rate of failure in the
routine DUS group.
Statistical analysis was performed using Rev-Man 5.2 (The
Nordic Cochrane Centre, The Cochrane Collaboration,
Copenhagen, Denmark).
RESULTS
The search identiﬁed 468 articles, of which ﬁve RCTs were
eligible for inclusion in the meta-analysis.11e15 The ﬂow
chart of the systematic review is shown in Fig. 1. The
methodological quality of the studies was fair, as depicted
in Table 1 (none scored > 3 on the Jadad scale), mostly
because it was impossible to blind the surgeons to treat-
ment groups as it was necessary for them to base their
decision about AVF creation on the details of the pre-
operative assessment. The risk of bias assessment of the
included RCTs is shown in Table 2, and shows that the
quality of three of the ﬁve studies was mediocre, and that
the evidence base for the conclusions was moderate.
Among the ﬁve analyzed studies (total of 574 patients),
only four reported the immediate failure rate. Two of these
four found a signiﬁcantly reduced immediate failure rate
when pre-operative DUS mapping was performed,11,14 while
Table 1. Baseline characteristics of included studies (randomized controlled trials).
Study Comparison (n) Forearm ﬁstulae
(n)
DUS criteria Outcome measures Jadad score
(R þ DB þ WD)
Smith et al.15 Routine (47) vs.
selective US (47)
Routine (20)
Selective (27)
Artery and vein 2 mm 30 day failure rate 2 þ 0 þ 1 ¼ 3
Ferring et al.14 Routine (112) vs.
selective US (106)
Routine (63)
Selective (64)
Artery and vein 2 mm
(3 mm at elbow)
Immediate and primary
failure, 1 year assisted
patency
2 þ 0 þ 1 ¼ 3
Mihmanli
et al.11
Routine US (72) vs.
clinical examination
only (52)
Routine (72)
Clinical
examination (52)
Vessel diameters
and other
parametersa
Immediate success rate 1 þ 0 þ 0 ¼ 1
Nursal et al.12 Routine US (35) vs.
clinical examination
only (35)
Routine (35)
Clinical
examination
(34)
Artery and vein >1.6 mm Immediate success rate
and 30 day patency
2 þ 0 þ 1 ¼ 3
Zhang et al.13 Routine US (33) vs.
clinical examination
only (35)
Routine (33)
Clinical
examination (35)
Vessel diameters
and other
parametersb
Immediate and 6 month
patency
1 þ 0 þ 1 ¼ 2
Note. DUS ¼ Doppler ultrasound; US ¼ ultrasound R ¼ randomization; DB ¼ double blinded; WD ¼ withdrawals and dropouts.
a Radial artery volume ﬂow.
b Peak velocities, pulsatility, and resistance indices.
Table 2. Risk of bias assessment of the included studies.
Domain Mihmanli et al.11 Nursal et al.12 Zhang et al.13 Ferring et al.14 Smith et al.15
Random sequence generation (selection bias) ? Low ? Low Low
Allocation concealment (selection bias) ? ? ? Low Low
Blinding of participants and personnel
(performance bias)
Low Low Low Low Low
Blinding of outcome assessment (detection bias) High High High High High
Incomplete follow up data (attrition bias) ? ? ? Low Low
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the immediate failure rate was 0.32 (95% CI 0.17e0.60;
p < .01) in favor of the DUS mapping group (Fig. 2).
Four studies reported early/midterm adequacy, deﬁned
as usability for haemodialysis at 30 days (two studies12,15),
at 6 months (one study13) and undeﬁned maturation rate
(one study14). The pooled OR for early/midterm adequacy
was 0.66 (95% CI 0.42e1.03; p ¼ .06), with a trend in favor
of the DUS mapping group (Fig. 3).
Only two studies reported 1 year patency rates in
KaplaneMeier format. In one, the assisted primary patency
was signiﬁcantly better in the routine DUS group (80% vs.
65%; p ¼ .01),14 while in the other the primary patency was
similar in both groups (p ¼ .77)12; no further analysis of theFigure 2. Forest plot illustrating the pooled estimate of the immediat
routine Doppler ultrasound mapping (US) vs. patients evaluated wit
with 95% conﬁdence intervals (CI).patency rates was performed. Visual inspection of the
funnel plots did not suggest publication bias, but interpre-
tation was limited by the small number of studies.
In only two studies was the comparison between routine
and selective DUS, and only in one of them was the per-
centage (34%) of patients in the selective arm who actually
had DUS mapping because of unsatisfactory clinical exam-
ination reported.15 In the remainder of the studies the
comparison was between routine DUS and clinical exami-
nation only (Table 1). Sensitivity analysis regarding early/
midterm adequacy and/or maturation rate was performed
in only these two studies.14,15 The pooled OR was 0.56 (95%
CI 0.33e0.95; p ¼ .03) in favor of the routine DUS mapping
group (Fig. 4)e arteriovenous ﬁstulae failure rate in patients with pre-operative
h clinical examination or selective US. Odds ratio (OR) is shown
Figure 3. Forest plot illustrating the pooled estimate of the early/midterm adequacy for hemodialysis in patients with pre-operative routine
Doppler ultrasound mapping (US) vs. patients evaluated with clinical examination or selective US. Odds ratio (OR) is shown with 95%
conﬁdence intervals (CI).
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Figure 4. Forest plot illustrating the pooled estimate of the early/midterm adequacy for hemodialysis and/or maturation in patients with
pre-operative routine Doppler ultrasound mapping (US) vs. patients evaluated with selective US. Odds ratio (OR) is shown with 95%
conﬁdence intervals (CI).
Necessity for Routine Pre-operative Ultrasound Mapping 603DISCUSSION
Traditionally, pre-operative evaluation before AVF creation
starts with the clinical examination; however, its reliability is
controversial and has been questioned by many authors.
Wells et al. examined the correlation between clinical and
ultrasonographic ﬁndings before AVF placement in 146
consecutive patients; of those in whom DUS mapping was
considered unnecessary by clinical examination, subsequent
DUS mapping altered the initial surgical plan in only one
patient.16 In contrast, in a small prospective study the DUS
mapping altered the surgical planning, which was based on
clinical examination, in 30% of patients.17 In another similar
study 23% of patients had vascular pathology identiﬁed by
DUS, which altered the access plan suggested by clinical
examination alone.18
Although current guidelines recommend routine DUS
mapping before the creation of AVF,7,8 no consensus exists
and, based on the insufﬁcient data favoring its routine use,
selective DUS has been suggested instead.19,20 Current
guidelines are based on only one randomized study,11 which
compared routine DUS mapping with clinical examination
only, and did not mention the potential beneﬁts of selective
DUS.
Four non-randomized comparative studies reported data
from routine DUS before AVF creation and compared them
with historical or concurrent controls.2e5 All concluded that
routine DUS signiﬁcantly increased autologous vein AVF
creation over synthetic grafts, while three of the studies also
found signiﬁcant beneﬁts to AVF patency, AVF adequacy, or
early failure rate (Table 3). However, an increased AVF failure
rate was reported following routine DUSmapping, which was
attributed to suboptimal vessel use, which would not have
been detected with clinical examination only.21The initial studies using historical controls were followed
by RCTs; ﬁve such RCTs addressed the controversial issue of
whether routine use of DUS should be the preferred pol-
icy.11e15 Three of these studies revealed a signiﬁcant beneﬁt
of the routine use of DUS (Table 1).11,13,14 Of the remaining
studies that failed to reveal statistical signiﬁcance, one was
underpowered as it was designed to detect a 27% difference,
whereas only a 15% difference was observed in favor of the
routine use of DUS policy.15 The second was the only trial
reporting no advantage of DUS; however, it recruited only
pre-selected patients, with normal pre-operative clinical
ﬁndings being exposed to selection bias.12 A recent meta-
analysis by Wong et al.6 included three of the existing
RCTs,11,12,14 and concluded that although there was some
beneﬁt in terms of the number of AVFs used for hemodialysis
in the routine DUS group the difference did not reach sta-
tistical signiﬁcance. However,Wong et al. did not analyze the
early failure rates and therefore missed cases where unnec-
essary surgical dissection failed to reveal suitable vessels;
focused on patients who successfully used the AVF; and
missed those who were transplanted, those who died, those
who switched to peritoneal dialysis, and those in whom renal
function recovered.6
In the present meta-analysis the pooled immediate fail-
ure rate was found to be signiﬁcantly reduced in the routine
DUS group, and the odds of immediate failure were almost
threefold less in patients receiving DUS mapping.
There was no statistically signiﬁcant difference between
the two groups regarding the early/midterm AVF adequacy
for hemodialysis, but a trend was revealed (p ¼ .06) in favor
of the routine DUS group. A less signiﬁcant trend was also
reported in the meta-analysis of Wong et al. (p ¼ .10),6
again in favor of the routine DUS group.6 However, in
Table 3. Baseline characteristics of non-randomized comparative studies.
Comparison Patients with
RDUS (n)
Proportion of AVF
placement over grafts (%)
Outcome (%)
Silva et al.2 Historical controls 108 63 vs. 14a Early failure 8.3 vs. 38.0a; 1 year
patency 83 vs. 48a
Allon et al.3 Historical controls 138 64 vs. 34a Adequacy of forearm AVF 54 vs. 34a
McGill et al.4 Historical controls w600 72 vs. 32 e
Ilhan et al.5 Concurrent controls 63 89 vs. 66a 6 month patency 93 vs. 80a
Note. RDUS ¼ Routine Doppler US mapping.
a Statistically signiﬁcant.
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selective DUS use a statistically signiﬁcant difference was
found, possibly because the two included studies were
those with a lower risk of bias, and reported attrition rates
of 15% and 18%, respectively (Table 2).14,15 The present
review increases the level of evidence for routine DUS use
and the subgroup analysis additionally revealed its signiﬁ-
cant beneﬁt over selective DUS regarding the early/
midterm adequacy and/or maturation rate.
There is no generally accepted “standard” for what con-
stitutes DUS mapping. Most studies suggest a minimum
arterial diameter of 2.0 mm for successful ﬁstula creation,
while venous evaluation should include a diameter of
>2.0e2.5 mm and continuity with the proximal central
veins, and the absence of obstruction.7 Among the included
studies, three assessed radial artery and cephalic vein di-
ameters,12,14,15 while in the other two, additional parame-
ters, such as radial artery volume ﬂow, peak velocities, and
pulsatility and resistance indices were measured.11,13
Among the weaknesses of this meta-analysis is that ad-
equacy which is related to the maturation rate and other
parameters, such as the outﬂow vein diameter, affect this
outcome22; however, such parameters were only taken into
account in one of the included RCTs,12 and therefore it is
not clear if the two groups were comparable with regard to
the outﬂow vein diameter. The different clinical examination
protocols in the included studies, the vague indications for
DUS in the “selective” arms, and the small number of
included patients are additional limitations. Nevertheless,
DUS mapping is a cheap and non-invasive procedure widely
available, and can be done preferentially by the operating
surgeon in a “one stop” clinic; ideally, it should be carried
out close to the date of surgery.19,20,23
In conclusion, according to the results of this meta-
analysis, pre-operative clinical examination should always
be supplemented with routine DUS vessel mapping before
the creation of an AVF. However, the low to moderate
quality of the included studies raises questions as to
whether the present meta-analysis could represent solid
level I evidence. Further studies on this topic are needed to
add signiﬁcant strength to the ﬁnal message. Despite the
moderate strength of these conclusions, such a policy
avoids negative surgical explorations and signiﬁcantly re-
duces the immediate failure rate, while having a minor
beneﬁt on the midterm adequacy of AVF for hemodialysis.
Clinical examination alone is not adequate to allow for ac-
curate AVF planning.ACKNOWLEDGMENTS
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